论文部分内容阅读
近年来,国内外采用大剂量甲基强的松龙冲击疗法治疗重症神经系统自家免疫疾病获得较好的疗效,以疗效迅速、疗程短、总剂量少及副作用轻等优点在临床应用日益广泛。为了评估甲基强的松龙冲击疗法治疗对急性神经炎的疗效,我们于1994年～1996年采用大剂量甲基强的松龙冲击疗法治疗急性视神经炎20例,取得良好效果,并与常量地塞米松疗法进行了临床病例对照研究,报道如下。 1 资料与方法 1.1 大剂量甲基强的松龙冲击疗法组(简称治疗组):病例为急性视神经炎患者共20例,男性12
In recent years, the domestic and international high-dose methylprednisolone impact therapy for the treatment of severe autoimmune diseases of the nervous system to obtain better efficacy, rapid response, short course, less total dose and side effects of light advantages in clinical application is increasingly widespread. In order to evaluate the efficacy of methylprednisolone therapy in the treatment of acute neuritis, we treated 20 cases of acute optic neuritis with high-dose methylprednisolone shock therapy from 1994 to 1996, and achieved good results. Dexamethasone therapy for clinical case-control study, reported as follows. 1 Materials and Methods 1.1 high-dose methylprednisolone impact therapy group (referred to as the treatment group): a case of acute optic neuritis in patients with a total of 20 cases, 12